As the constituents of CP was selected to examine the effects on breast cancer but via KEGG analysis (Table 6) it was found responsible in many cancers as colorectal cancer, renal cell carcinoma, pancreatic cancer, endometrial cancer, prostate cancer, melanoma, bladder cancer, small cell lung cancer, non-small cell lung cancer, hepatocellular carcinoma, and gastric cancer. This evidence concerns the gene CP and urinary bladder carcinoma.